Table 3 : Relation of Serum Annexin A2 (mean±SD) with clinical and serological
parameters in hepatocellular carcinoma group (n=20).


Parameter Character N/% Annexin (ng/ml) P-value

Sex Male
Female
9(45%)
11(55%)
33.85 ± 3.59 
33.51 ± 5.33
0.385

Age <50 years
>50 years
6(30%)
14(70%)
24.81 ± 4.55
23.9 ± 4.56
0.734

Serum ALT (U/L) <80
>80
5(25%)
15(75%)
24.44 ± 5.12
24.24 ± 5.54
0.862

Albumin, g/dL <3
>3
12(60%)
8(40%)
31.23± 5.21
31.48± 4.11
0.758

Platelets (x109 /L) <40
>40
7(35%)
13(65%)
36.98± 3.34
35.99± 3.23
0.51

HBsAg Positive
Negative
2(10%)
18(90%)
32.2 ± 2.5
31.45± 5.1
0.52

HCV RNA Positive
Negative
17 (85%)
3 (15%)
36.89 ± 5.22
27.11 ± 6.2
<0.001**

AFP (IU/ml) <50
>50
5 (25%)
15 (75%)
24.60 ± 7.60
24.22 ± 9.15
0.685

Tumour size Cm <5
>5
11(55%)
9(45%)
24.14 ± 5.78
36.11 ± 5.23
0.000***

TNM Staging Stages I-II
Stages III-IV
13(65%)
7(35%)
26.19 ± 5.31
36.67± 4.11
0.001**

Abdelgawad et al.Journal of Cancer Therapeutics and Research  2017 6:2DOI : 10.7243/2049-7962-6-2